Wey W
ORL J Otorhinolaryngol Relat Spec. 1979;41(5):301-11. doi: 10.1159/000275448.
At most interdisciplinary tumour centres, radiotherapy is of prime importance in the concept of therapy for the majority of the cases of laryngeal carcinoma treated, or it is even employed--exploratively and with curative intent--as the sole therapy at first. At all events initial radiotherapy occupies a dominant position today. Against this background the question is often discussed whether, after a 'low dose' has been attained (particularly in the case of a supraglottic tumour), a partial or total laryngectomy should be performed or the radiation dose substantially increased with the aim of obtaining a cure. However, the difficulties involved immediately after irradiation or later in recognizing a persistent or recurrent carcinoma and readily identifying it histologically may be very great. Various aspects of such situations--both diagnostic and therapeutic--are discussed in general and with reference to case histories.
在大多数跨学科肿瘤中心，放射治疗在大多数喉癌治疗病例的治疗理念中至关重要，或者甚至一开始就作为唯一的治疗方法进行探索性应用且具有治愈目的。无论如何，初始放射治疗如今占据主导地位。在此背景下，人们经常讨论这样一个问题：在达到“低剂量”（尤其是声门上肿瘤的情况）后，是应该进行部分或全喉切除术，还是大幅增加放射剂量以实现治愈。然而，照射后立即或之后识别持续性或复发性癌并通过组织学方法轻易确诊其存在的困难可能非常大。本文将结合病例对这些情况的各个方面——诊断和治疗方面——进行一般性讨论。
